Andrea Pfeifer
Förmögenhet: 9 M $ per 2026-06-30
Förmögenhet: 9 M $ per 2026-06-30
Andrea Pfeifer was the founder of AC Immune SA, founded in 2003, serving as Chief Executive Officer & Director from 2016 to 2026.
Dr. Pfeifer is also the founder of Inventages II..
Dr. Pfeifer currently holds the position of Chairman at BioMedInvest AG.
I and AB2 Bio Ltd. Dr. Pfeifer is an Independent Member of the Supervisory Board at Symrise AG since 2011.
Dr. Pfeifer is a Professor at the University of Lausanne.
Former positions include Chairman at BioMedPartners AG, Member of the Supervisory Board at 2invest AG, Principal at Nestlé USA, Inc., and Head of Global Research at Nestlé Nespresso SA. Education includes a doctorate from Wuerzburg Schweinfurt University of Applied Sciences, conferred in 1984.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
AC IMMUNE SA 3,77 % | 2026-05-15 | 3 834 288 ( 3,77 % ) | 9 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| SYMRISE AG | Direktör/Styrelseledamot | 2011-05-01 |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance Acts as Venture Capital Fund | Ordförande | - |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
| AC IMMUNE SA | Grundare | 2026-06-11 |
| 2INVEST AG | Direktör/Styrelseledamot | 2012-10-18 |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Designs and manufactures espresso machines | Företagsledare/Principal | - |
Inventages II
Inventages II Investment ManagersFinance Acts as Venture Capital Fund | Grundare | - |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Ordförande | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
2invest AG
2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Symrise AG
Symrise AG Chemicals: SpecialtyProcess Industries Produces fragrances and flavorings for taste, nutrition, health & scents | Process Industries |
Nestlé USA, Inc.
Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Manufactures and supplies baking, coffee, beverages, pet care, bottled water, frozen meals & infant nutrition products | Process Industries |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Designs and manufactures espresso machines | Producer Manufacturing |
Wuerzburg Schweinfurt University of Applied Sciences
Wuerzburg Schweinfurt University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Finance |
Inventages II
Inventages II Investment ManagersFinance Acts as Venture Capital Fund | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån